ImmunoPrecise Antibodies
Quarterly Financials
| Values in thousands | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 |
|---|---|---|---|---|
Revenue | $4,090 | $4,124 | $3,161 | $6,981 |
Gross Profit | 2,423 | 2,662 | 1,527 | 4,460 |
EBITDA | -3,670 | -2,987 | -3,237 | -988 |
EBIT | -3,883 | -3,194 | -4,179 | -1,901 |
Net Income | -3,865 | -3,195 | -2,959 | -2,161 |
Net Change In Cash | 4,090 | 4,124 | 3,161 | 6,981 |
Free Cash Flow | -2,955 | -2,944 | -4,495 | -1,499 |
Cash | 14,181 | 16,508 | 4,897 | 10,665 |
Basic Shares | 46,515 | 46,156 | 39,637 | 33,118 |
Annual Financials
| Values in thousands | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
Revenue | $24,520 | $24,518 | $20,665 | $19,364 |
Gross Profit | 13,548 | 12,053 | 11,563 | 10,983 |
EBITDA | -28,855 | -22,949 | -21,037 | -11,994 |
EBIT | -33,974 | -28,684 | -27,722 | -15,763 |
Net Income | -30,234 | -26,115 | -26,560 | -16,709 |
Net Change In Cash | 24,520 | 24,518 | 20,665 | 19,364 |
Free Cash Flow | -7,209 | -5,643 | -21,328 | -11,178 |
Cash | 10,665 | 3,459 | 8,280 | 29,965 |
Basic Shares | 33,385 | 25,636 | 24,897 | 19,688 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-01-31 | -$0.05 |
2025-10-31 | -$0.07 |
2025-07-31 | -$0.09 |
2025-04-30 | -$0.05 |